Utama › Aterosklerosis › Washington
Kajian klinikal Aterosklerosis di Washington
6 kajian untuk Aterosklerosis sedang mencari peserta di lokasi di Washington.
Bandar di Washington
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Eastside Research Associates, LLC dba Era Health Research, Redmond
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- ERA Health Research - CardioNow - Lynnwood, Lynnwood
- Eastside Research Associates, Redmond
- Rainier Clinical Research Center, Renton
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- VA Puget Sound Healthcare System, Seattle
- Velocity Clinical Research - Spokane, Spokane
Mengambil pesertaFasa 3
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Eastside Research Associates, Redmond
Mengambil pesertaFasa 3
Umur 45 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07613294A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- University of Washington, Seattle
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06875973Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.